BRAF V600E and survival benefit of anti-EGFR monoclonal antibody (mAb) therapy for metastatic colorectal cancer (mCRC): A meta-analysis.

被引：0
|
作者：
Sorich, Michael
Rowland, Andrew
Dias, Mafalda
McKinnon, Ross Allan
Kichenadasse, Ganessan
Wiese, Michael
Karapetis, Christos Stelios
机构：
[1] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[2] Flinders Univ S Australia, Flinders Med Ctr, Adelaide, SA 5001, Australia
[3] Univ S Australia, Adelaide, SA 5001, Australia
[4] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Adelaide, SA 5001, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14605
引用
收藏
页数：1
相关论文
共 50 条
  • [1] BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
    Mao, Chen
    Liao, Ru-Yan
    Qiu, Li-Xin
    Wang, Xi-Wen
    Ding, Hong
    Chen, Qing
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (04) : 2219 - 2223
  • [2] BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
    Chen Mao
    Ru-Yan Liao
    Li-Xin Qiu
    Xi-Wen Wang
    Hong Ding
    Qing Chen
    Molecular Biology Reports, 2011, 38 : 2219 - 2223
  • [3] BRAF V600E Mutation as a Predictive Factor of Anti-EGFR Monoclonal Antibodies Therapeutic Effects in Metastatic Colorectal Cancer: a Meta-analysis
    Qi Wang
    Wei-guo Hu
    Qi-bin Song
    Jia Wei
    Chinese Medical Sciences Journal, 2014, 29 (04) : 197 - 203
  • [4] Response to BRAF inhibitors combined with anti-EGFR after previous anti-EGFR exposure for BRAF V600E mutant metastatic colorectal cancer patients
    Hafliger, E.
    Boccaccino, A.
    El-Khoury, R.
    Perret, A.
    Pietrantonio, F.
    Pilla, L.
    Lecomte, T.
    Scartozzi, M.
    Soularue, E.
    Salvatore, L.
    Bourgeois, V.
    Salati, M.
    Vaillant, J. N.
    Gallois, C.
    Lonardi, S.
    Cremolini, C.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S554 - S554
  • [5] Primary tumor site and anti-EGFR monoclonal antibody benefit in metastatic colorectal cancer: a meta-analysis
    Li, Dandan
    Fu, Qiang
    Li, Man
    Li, Jun
    Yin, Can
    Zhao, Jin
    Li, Feng
    FUTURE ONCOLOGY, 2017, 13 (12) : 1115 - 1127
  • [6] Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies
    Dandan Cui
    Dan Cao
    Yu Yang
    Meng Qiu
    Ying Huang
    Cheng Yi
    Molecular Biology Reports, 2014, 41 : 1291 - 1298
  • [7] Effect of BRAF V600E mutation on tumor response of anti-EGFR monoclonal antibodies for first-line metastatic colorectal cancer treatment: a meta-analysis of randomized studies
    Cui, Dandan
    Cao, Dan
    Yang, Yu
    Qiu, Meng
    Huang, Ying
    Yi, Cheng
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1291 - 1298
  • [8] Immunohistochemical analysis of BRAF V600E antibody in colorectal cancer
    Ben Rejeb, S.
    Sakly, S.
    Bahloul, R.
    Souai, F.
    Chouch, A.
    VIRCHOWS ARCHIV, 2024, 485 : S471 - S472
  • [9] Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC)
    Atreya, Chloe Evelyn
    Van Cutsem, Eric
    Bendell, Johanna C.
    Andre, Thierry
    Schellens, Jan H. M.
    Gordon, Michael S.
    McRee, Autumn Jackson
    O'Dwyer, Peter J.
    Muro, Kei
    Tabernero, Josep
    van Geel, Robin
    Sidhu, Roger
    Greger, James G.
    Rangwala, Fatima A.
    Motwani, Monica
    Wu, Yuehui
    Orford, Keith W.
    Corcoran, Ryan Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer
    Rowland, A.
    Dias, M. M.
    Wiese, M. D.
    Kichenadasse, G.
    McKinnon, R. A.
    Karapetis, C. S.
    Sorich, M. J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (12) : 1888 - 1894
12345